Form D · Biotechnology
VENTRUS BIOSCIENCES INC
New York, NY · CIK 0001426800
Offering snapshot reported May 24, 2010 · SEC filing
- Reported sold
- $700K Offering amount: $750K
- Investors reported
- 8 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- May 6, 2010 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 24, 2010 | Initial | $700,000 | No comparison | 8 | SEC filing |
| Apr 26, 2010 | Amendment | $2,725,000 | $575,000vs Mar 12, 2010 | 44 | SEC filing |
| Mar 12, 2010 | Initial | $2,150,000 | No comparison | 35 | SEC filing |
| Jun 24, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Feb 7, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Debt, Option to acquire
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $289K
- Finders' fees
- $0
- Form D file number
- 021-142439
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| National Securities Corporation | 7569 |
Source: Form D, filed May 24, 2010. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Joseph Felder | Director |
| Thom Rowland | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
787 7 Th Avenue 48 Th Floor
New York, NY, 10019
New York, NY, 10019